Showing 1 - 10 of 36
The diversity of knowledge and skills is considered to be good for scientific inquiry. We challenge this general statement by analyzing to what extent the diversity in knowledge background of research teams affects their inventive performance. Using patent data assigned to 60 European...
Persistent link: https://www.econbiz.de/10010858973
Intensification of university-industry interactions raises concerns about the potential negative impact it may have on the pace of scientific progress. This paper analyzes the relationship between academic patenting, research collaboration and quality of scientic output in a panel of 268...
Persistent link: https://www.econbiz.de/10009216310
Persistent link: https://www.econbiz.de/10010863238
This paper first describes the so-called patent backlogs and assesses the extent to which they might affect the examination process in major patent offices. Second it puts forward that the root causes of these backlogs in Europe and in the US are different. The backlog at the United States...
Persistent link: https://www.econbiz.de/10009195195
We analyze the impact of national pharmaceutical regulation on the launch delay of new chemical entities approved by the EMEA's centralized procedure. We find that direct price control regimes have a significantly negative impact on the launch timing. These results cannot be found when...
Persistent link: https://www.econbiz.de/10010264890
This paper analyses the consequences for the European Patent System (EPS) of the recently ratified London Agreement (LA), which aims to reduce the translation requirements for patent validation procedures in 15 out of 34 national patent offices. The simulations suggest that the cost of patenting...
Persistent link: https://www.econbiz.de/10010317310
This paper argues that the consequences of the 'fragmentation' of the European patent system are more dramatic than the mere prohibitive costs of maintaining a patent in force in many jurisdictions. First, detailed analysis of judicial systems in several European countries and four case studies...
Persistent link: https://www.econbiz.de/10010317346
We analyze the impact of national pharmaceutical regulation on the launch delay of new chemical entities approved by the EMEA’s centralized procedure. We find that direct price control regimes have a significantly negative impact on the launch timing. These results cannot be found when...
Persistent link: https://www.econbiz.de/10005755111
This paper argues that the consequences of the ‘fragmentation’ of the European patent system are more dramatic than the mere prohibitive costs of maintaining a patent in force in many jurisdictions. First, detailed analysis of judicial systems in several European countries and four case...
Persistent link: https://www.econbiz.de/10005788910
This article argues that the consequences of the ‘fragmentation’ of the European patent system are more dramatic than the mere prohibitive costs of maintaining a patent in force in many jurisdictions. The prevalence of national jurisdictions, which are highly heterogeneous in their costs and...
Persistent link: https://www.econbiz.de/10008578182